• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物活性天然螺内酯型 6,7---贝壳杉烷二萜类化合物及其合成衍生物。

Bioactive Natural Spirolactone-Type 6,7---Kaurane Diterpenoids and Synthetic Derivatives.

机构信息

Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, and School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.

Department of Medicinal Chemistry and State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.

出版信息

Molecules. 2018 Nov 8;23(11):2914. doi: 10.3390/molecules23112914.

DOI:10.3390/molecules23112914
PMID:30413071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6278314/
Abstract

Diterpenoids are widely distributed natural products and have caused considerable interest because of their unique skeletons and antibacterial and antitumor activities and so on. In light of recent discoveries, -kaurane diterpenoids, which exhibit a wide variety of biological activities, such as anticancer and anti-inflammatory activities, pose enormous potential to serve as a promising candidate for drug development. Among them, spirolactone-type 6,7---kaurane diterpenoids, with interesting molecular skeleton, complex oxidation patterns, and bond formation, exhibit attractive activities. Furthermore, spirolactone-type diterpenoids have many modifiable sites, which allows for linking to various substituents, suitable for further medicinal study. Hence, some structurally modified derivatives with improved cytotoxicity activities are also achieved. In this review, natural bioactive spirolactone-type diterpenoids and their synthetic derivatives were summarized.

摘要

二萜类化合物广泛分布于自然界,由于其独特的骨架结构以及具有抗菌、抗肿瘤等活性而引起了人们的广泛关注。鉴于最近的发现,-贝壳杉烷二萜类化合物具有广泛的生物活性,如抗癌和抗炎活性等,具有巨大的潜力成为药物开发的有前途的候选物。其中,螺内酯型 6,7---贝壳杉烷二萜类化合物具有有趣的分子骨架、复杂的氧化模式和键形成方式,表现出吸引人的活性。此外,螺内酯型二萜类化合物具有许多可修饰的位点,允许与各种取代基连接,适合进一步的药物研究。因此,还实现了一些结构修饰的衍生物,具有提高的细胞毒性活性。在本综述中,总结了天然生物活性螺内酯型二萜类化合物及其合成衍生物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/20aa9886bd6c/molecules-23-02914-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/82fa70664dab/molecules-23-02914-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/911195b02400/molecules-23-02914-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/d80b379749ab/molecules-23-02914-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/e09739e199c7/molecules-23-02914-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/0867efe412c8/molecules-23-02914-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/e0d52de63cb6/molecules-23-02914-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/0beec865e31a/molecules-23-02914-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/3e5db1f8ad20/molecules-23-02914-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/20aa9886bd6c/molecules-23-02914-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/82fa70664dab/molecules-23-02914-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/911195b02400/molecules-23-02914-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/d80b379749ab/molecules-23-02914-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/e09739e199c7/molecules-23-02914-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/0867efe412c8/molecules-23-02914-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/e0d52de63cb6/molecules-23-02914-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/0beec865e31a/molecules-23-02914-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/3e5db1f8ad20/molecules-23-02914-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0144/6278314/20aa9886bd6c/molecules-23-02914-sch006.jpg

相似文献

1
Bioactive Natural Spirolactone-Type 6,7---Kaurane Diterpenoids and Synthetic Derivatives.生物活性天然螺内酯型 6,7---贝壳杉烷二萜类化合物及其合成衍生物。
Molecules. 2018 Nov 8;23(11):2914. doi: 10.3390/molecules23112914.
2
Bioactive enmein-type 6,7-seco-ent-kaurane diterpenoids: natural products, synthetic derivatives and apoptosis related mechanism.生物活性桉烷型 6,7-裂环-ent-贝壳杉二萜:天然产物、合成衍生物及凋亡相关机制。
Arch Pharm Res. 2018 Nov;41(11):1051-1061. doi: 10.1007/s12272-018-1078-3. Epub 2018 Sep 21.
3
The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.奥多灵转化为螺内酯型或依美琴型二萜:新型潜在抗癌剂——ent-6,7-断键奥多灵衍生物的合成与生物评价。
Eur J Med Chem. 2012 Jun;52:242-50. doi: 10.1016/j.ejmech.2012.03.024. Epub 2012 Mar 23.
4
Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.硫化氢供体型贝壳杉烷和螺内酯型 6,7-裂贝壳杉烷衍生物的设计、合成及抗增殖活性。
Eur J Med Chem. 2019 Sep 15;178:446-457. doi: 10.1016/j.ejmech.2019.06.016. Epub 2019 Jun 6.
5
Recent progress in the development of natural ent-kaurane diterpenoids with anti-tumor activity.具有抗肿瘤活性的天然 ent-贝壳杉烷二萜类化合物的研究进展。
Mini Rev Med Chem. 2011 Sep;11(10):910-9. doi: 10.2174/138955711796575416.
6
Recent advances in the synthesis of -kaurane diterpenoids.-贝壳杉烷二萜类化合物合成的最新进展。
Nat Prod Rep. 2022 Jan 26;39(1):119-138. doi: 10.1039/d1np00028d.
7
Diterpenoid lead stevioside and its hydrolysis products steviol and isosteviol: Biological activity and structural modification.二萜类先导甜菊苷及其水解产物甜菊醇和异甜菊醇:生物活性和结构修饰。
Eur J Med Chem. 2018 Aug 5;156:885-906. doi: 10.1016/j.ejmech.2018.07.052. Epub 2018 Jul 24.
8
Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives.新型 ent-贝壳杉烷衍生物的合成、细胞毒性及抗疟活性。
Eur J Med Chem. 2013 Apr;62:168-76. doi: 10.1016/j.ejmech.2012.12.010. Epub 2012 Dec 20.
9
Cytotoxic, apoptotic, and sensitization properties of ent-kaurane-type diterpenoids from Croton tonkinensis Gagnep on human liver cancer HepG2 and Hep3b cell lines.东京巴豆(Croton tonkinensis Gagnep)中贝壳杉烷型二萜对人肝癌HepG2和Hep3b细胞系的细胞毒性、凋亡及致敏特性
Fundam Clin Pharmacol. 2016 Apr;30(2):137-46. doi: 10.1111/fcp.12176. Epub 2016 Jan 18.
10
Recent Developments in the Syntheses of C-20-Oxygenated ent-Kaurane Diterpenoids.C-20-氧代贝壳杉烷二萜类化合物的合成研究进展。
Chempluschem. 2024 Jun;89(6):e202300676. doi: 10.1002/cplu.202300676. Epub 2024 Mar 19.

引用本文的文献

1
New Derivatives of Caracasine Acid with Anti-Leukemic Activity and Limited Effectiveness in Spheroid Cultures.具有抗白血病活性且在球体培养中有效性有限的加拉卡辛酸新衍生物。
Pharmaceuticals (Basel). 2025 Jul 15;18(7):1043. doi: 10.3390/ph18071043.
2
Natural Enantiomers: Occurrence, Biogenesis and Biological Properties.天然对映体:存在、生物发生和生物特性。
Molecules. 2022 Feb 14;27(4):1279. doi: 10.3390/molecules27041279.
3
Sesquiterpene Lactones and Diterpenes: Promising Therapeutic Candidates for Infectious Diseases, Neoplasms and Other Chronic Disorders.

本文引用的文献

1
Diterpenoid lead stevioside and its hydrolysis products steviol and isosteviol: Biological activity and structural modification.二萜类先导甜菊苷及其水解产物甜菊醇和异甜菊醇:生物活性和结构修饰。
Eur J Med Chem. 2018 Aug 5;156:885-906. doi: 10.1016/j.ejmech.2018.07.052. Epub 2018 Jul 24.
2
Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation.具有改善的抗增殖选择性的布雷菲德菌素A与氮芥的新型杂化物:设计、合成及抗肿瘤生物学评价。
Eur J Med Chem. 2018 Apr 25;150:53-63. doi: 10.1016/j.ejmech.2018.02.088. Epub 2018 Mar 1.
3
倍半萜内酯和二萜类化合物:传染病、肿瘤及其他慢性疾病的潜在治疗候选物。
Molecules. 2021 Feb 26;26(5):1251. doi: 10.3390/molecules26051251.
4
Three new ent-abietane diterpenoids from the roots of Euphorbia fischeriana and their cytotoxicity in human tumor cell lines.三种新的贝壳杉烷二萜类化合物来自佛肚树的根及其对人肿瘤细胞系的细胞毒性。
Arch Pharm Res. 2019 Jun;42(6):512-518. doi: 10.1007/s12272-019-01151-y. Epub 2019 Apr 17.
Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
新型恩贝因型二萜类杂种与氮芥的偶联:抗癌治疗有前景候选物的合成。
Eur J Med Chem. 2018 Feb 25;146:588-598. doi: 10.1016/j.ejmech.2018.01.069. Epub 2018 Feb 4.
4
Recent advances in discovery and development of natural products as source for anti-Parkinson's disease lead compounds.天然产物作为抗帕金森病先导化合物来源的发现与开发的最新进展。
Eur J Med Chem. 2017 Dec 1;141:257-272. doi: 10.1016/j.ejmech.2017.09.068. Epub 2017 Sep 30.
5
Lipid lowering agents of natural origin: An account of some promising chemotypes.天然来源的降脂药物:一些有前途的化学型的描述。
Eur J Med Chem. 2017 Nov 10;140:331-348. doi: 10.1016/j.ejmech.2017.09.020. Epub 2017 Sep 14.
6
Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions.纳米白蛋白结合型紫杉醇在胰腺癌中的应用:当前证据与未来方向。
World J Gastroenterol. 2017 Aug 28;23(32):5875-5886. doi: 10.3748/wjg.v23.i32.5875.
7
6,7-Seco-ent-Kauranoids Derived from Oridonin as Potential Anticancer Agents.6,7-断-贝壳杉烷二萜类衍生物源于冬凌草甲素作为潜在的抗癌药物。
J Nat Prod. 2017 Sep 22;80(9):2391-2398. doi: 10.1021/acs.jnatprod.7b00057. Epub 2017 Sep 13.
8
Diterpenoids from Isodon species: an update.Isodon 属二萜类化合物:更新。
Nat Prod Rep. 2017 Aug 30;34(9):1090-1140. doi: 10.1039/c7np00027h.
9
Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.天然生物碱作为 P-糖蛋白抑制剂逆转肿瘤多药耐药。
Eur J Med Chem. 2017 Sep 29;138:273-292. doi: 10.1016/j.ejmech.2017.06.047. Epub 2017 Jun 27.
10
Nitric oxide-releasing derivatives of brefeldin A as potent and highly selective anticancer agents.作为强效且高选择性抗癌药物的布雷菲德菌素 A 的一氧化氮供体型衍生物。
Eur J Med Chem. 2017 Aug 18;136:131-143. doi: 10.1016/j.ejmech.2017.05.018. Epub 2017 May 5.